Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Shiga Toxins

Insgesamt 9 ergebnisse

NCT00004465

Beendet

Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Bedingungen: Hemolytic Uremic Syndrome
NCT02205541

Abgeschlossen

Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU

Bedingungen: Hemolytic Uremic Syndrome of Childhood
NCT01410916

Abgeschlossen

Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)

Bedingungen: Shiga-like Toxin-producing Escherichia Coli
NCT03275792

Zurückgezogen

Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion

Bedingungen: Hemolytic-Uremic Syndrome
NCT03388216

Abgeschlossen

Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin F(ab')2 Fragment (INM004) in Healthy Volunteers

Bedingungen: Healthy Volunteers
NCT01252199

Abgeschlossen

Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2

Bedingungen: Shiga Toxin Producing Bacterial Infection
NCT04132375

Rekrutierung

Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS

Bedingungen: Bloody Diarrhea; STEC, Unspecified; Hemolytic-Uremic Syndrome; Pediatric Kidney Disease
NCT01406288

Abgeschlossen

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4

Bedingungen: Hemolytic-uremic Syndrome; Escherichia Coli Infections
NCT03362970

Rekrutierung

Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia

Bedingungen: Diarrhea Bloody